Nutriband sets dates for 25% preferred stock dividend

Nutriband Inc. (NASDAQ: NTRB) announced key dates for its 25% preferred stock dividend distribution. Shareholders of record on July 25, 2025 will receive one preferred share for every four shares of common stock held, with the pay date scheduled for August 5.

Each preferred share will be convertible to one share of common stock following FDA approval of the company's AVERSA Fentanyl product. Unconverted preferred shares will be entitled to annual cash dividends paid from company profits as determined by the board of directors.

The Orlando, Florida-based company develops transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating AVERSA technology. The AVERSA abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent abuse, diversion, misuse, and accidental exposure of drugs with abuse potential.

The company holds patents for its technology in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia. The information was provided in a company press release.

You May Also Be Interested In

• Vaxart gets $29M BARDA funding to advance COVID pill vaccine data
• Core & Main launches $750M senior notes offering due 2034
• OFA Group selected for Japan music park development project